ROGER G PHD STOLL
CIK 1191281 · Executive Chairman · last filed 2024-05-28
ROGER G PHD STOLL is an Executive Chairman who has filed 47 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for DCTH, was dated Jul 9, 2024. Across all open-market trades the lifetime net is +$352.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $61.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$61.13M
3
47
$352.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DCTH | Director | 9,309 | $12.43 | $115.7K | $142.4K | 22 | 2024-05-28 |
| Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Director | 40,000 | — | — | $167.3K | 15 | 2014-01-24 |
| COR | Executive Chairman | 200,000 | $305.06 | $61.01M | $43.1K | 8 | 2009-08-24 |
Recent Filings
47 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-07-09 | DCTH | Notice (144) | −1,000 | -$7.3K | EDGAR |
| 2024-05-28 | DCTH | Mixed | — | $0 | EDGAR |
| 2023-06-21 | DCTH | Grant (A) | — | $0 | EDGAR |
| 2022-05-06 | DCTH | Grant (A) | — | $0 | EDGAR |
| 2021-08-09 | DCTH | Grant (A) | — | $0 | EDGAR |
| 2020-11-25 | DCTH | Grant (A) | — | $0 | EDGAR |
| 2020-05-08 | DCTH | Conv (C) | +9,300 | $0 | EDGAR |
| 2019-07-26 | DCTH | Buy (P) | — | $0 | EDGAR |
| 2019-02-05 | DCTH | Grant (A) | — | $0 | EDGAR |
| 2018-10-23 | DCTH | Buy (P) | +4,900 | $8.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.